H1N1 (Swine Flu) Prevention: Antivirals, Vaccination, and Hygiene
Influenza A(H1N1)pdm09 circulates seasonally. Prevention combines pharmaceutical and non-pharmaceutical measures.
Antiviral Prophylaxis
- Oseltamivir (Tamiflu): 75 mg daily × 7-10 days post-exposure; 75 mg daily during outbreak in closed settings (nursing homes).
- Zanamivir (Relenza): 10 mg inhaled daily × 7-10 days. Not for asthma/COPD (bronchospasm risk).
- Baloxavir marboxil (Xofluza): Single dose post-exposure prophylaxis (approved ≥12 years).
Not substitutes for vaccination. Resistance emerges with monotherapy; use judiciously.
Vaccination
- Annual quadrivalent inactivated (IIV) or recombinant (RIV) or live attenuated (LAIV) vaccine.
- Updated for circulating strains (WHO GISRS).
- Best timing: September-October (before peak).
- Priority: ≥6 months, especially pregnant, chronic disease, immunocompromised, healthcare workers.
Non-Pharmaceutical Interventions
- Hand hygiene (soap/water or ≥60% alcohol sanitizer).
- Respiratory etiquette (mask, tissue, elbow cough).
- Stay home when febrile/respiratory symptoms.
- Ventilation, air filtration (HEPA, UVGI).
- Avoid crowded indoor spaces during peak.
Treatment (If Infected)
Antivirals within 48h of onset reduce duration ~1 day and complications. High-risk patients: treat regardless of duration.
Layered protection works best.
Viral Infections - Related Articles
- Zoonotic Diseases in Cats: Risks & Prevention
- Viral Joint and Muscle Pain: Causes, Symptoms & Types
- Chickenpox Incubation Period: What to Expect & Symptoms
- Edward Jenner and the Discovery of Vaccination: A Historical Overview
- Do Viruses Enter Through Cuts? Risks and Prevention
- Epstein-Barr Virus (EBV): Supportive Care & When to Escalate
- Virus Diagnosis: Symptoms, Tests & What to Expect
